Pasithea Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.22	6.92	16.33	33.09	52.97
Cash & Short-Term Investments	4.22	6.92	16.33	33.09	52.97
Cash Growth	-54.88%	-57.61%	-50.64%	-37.53%	-
Other Receivables	-	-	0.04	-	-
Total Trade Receivables	-	-	0.04	-	-
Other Current Assets	1.31	0.45	0.32	0.99	0.33
Total Current Assets	5.53	7.37	16.69	34.08	53.3
Net Property, Plant & Equipment	6.84	0.12	0.22	0.63	0.02
Other Intangible Assets	-	7.31	7.94	8.57	-
Goodwill	1.26	1.26	1.26	1.26	-
Other Long-Term Assets	-	-	-	0.64	-
Total Assets	13.63	16.06	26.12	45.18	53.32
Accounts Payable	1.34	1.12	2.55	1.48	0.45
Current Portion of Leases	-	-	0.08	0.16	-
Other Current Liabilities	0.04	-	-	0.24	-
Total Current Liabilities	1.38	1.12	2.63	1.88	0.45
Long-Term Leases	-	-	-	0.34	-
Other Long-Term Liabilities	0.05	0.16	0.08	0.46	1.45
Total Long-Term Liabilities	0.05	0.16	0.08	0.8	1.45
Total Liabilities	1.42	1.28	2.72	2.68	1.9
Common Stock	0	0	0	0	0.02
Additional Paid-in Capital	72.09	64.37	58.72	61.86	53.63
Accumulated Other Comprehensive Income	0.02	-0.01	-0	-0	-0.01
Retained Earnings	-59.9	-49.58	-35.32	-19.36	-2.21
Shareholders' Equity	12.21	14.78	23.4	42.5	51.42
Total Liabilities & Equity	13.63	16.06	26.12	45.18	53.32
Total Debt	-	0	0.08	0.5	0
Net Cash (Debt)	4.22	6.92	16.25	32.58	52.97
Net Cash Growth	-38.99%	-57.40%	-50.13%	-38.48%	-
Net Cash Per Share	1.02	6.32	13.25	25.81	101.81
Book Value	12.21	14.78	23.4	42.5	51.42
Book Value Per Share	2.95	13.49	19.08	33.67	98.84
Tangible Book Value	10.94	6.21	14.19	32.66	51.42
Tangible Book Value Per Share	2.64	5.66	11.57	25.88	98.84

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q